Annual Congress Glasgow 2004

Saturday, 04.09.2004
Sunday, 05.09.2004
Monday, 06.09.2004
Tuesday, 07.09.2004
Wednesday, 08.09.2004

Citations should be made in the following way: Authors. Title. Eur Respir J 2004; 24: Suppl. 48, abstract number.

Material from 2004:

3888 Abstracts
555 Slide presentations
20 Webcasts
96 Handouts

Material from 2004: Show

Improvements in delivery of inhaled agents

Thematic Poster Session
Chairs: S. Centanni (Milan, Italy), S. Hashimoto (Tokyo, Japan)

Download all media

Development and validation of high performance computing simulation of respiratory tract of inhaled drug and pharmacokinetics E. Demoncheaux, J. Fenner, B. Brook, R. Hose, P. Lawford, E. van Beek, T. Higenbottam, K. McCormack, D. Mayer, H. Kauczor, S. Nichols (Sheffield, Holmes Chapel, United Kingdom; Mainz, Germany)
Evaluation of a guided breathing manoeuvre for nebulised drug delivery in COPD patients D. Seamark, I. Prince, M. Pinnuck, J. Denyer (Honiton, Bognor Regis, United Kingdom)
Small airway function in asthma patients treated with an ultrafine inhaled steroid aerosol S. Verbanck, D. Schuermans, M. Paiva, W. Vincken (Brussels, Belgium)
An exploratory scintigraphic study of lung deposition of ^99mTc-DTPA radiolabelled saline when using three different breathing manoeuvres J. Denyer, I. Prince, S. Newman, D. Clark, J. Conway (Bognor Regis, Nottingham, Southampton, United Kingdom)
In vitro performance of the prodose AAD® handheld - a new portable aerosol delivery system J. Denyer, I. Prince, L. Hardaker, J. Young, S. Tanaka (Bognor Regis, United Kingdom; Kyoto, Japan)
Performance characteristics of a multi dose dry powder inhaler (MDPI) with respect to the use of different deaggregation systems S. Mueller, B. Fyrnys, A. H. De Boer (Frankfurt am Main, Germany; Groningen, The Netherlands)
Development of formoterol fumarate dihydrate powder for inhalation (6 µg and 12 µg per dose) delivered through a multi dose dry powder inhaler (MDPI) S. Mueller, B. Fyrnys (Frankfurt am Main, Germany)
Variability of budesonide (BUD) fine particle dose (FPD) delivered through two multiple dose dry powder inhalers (MDPI) K. Marschall, U. Munzel, M. Wedel, B. Fyrnys (Frankfurt, Germany)
Pharmaceutical development of salmeterol HFA metered dose inhaler I. D. Peyron, I. L. Britto, L. B. Benissan, B. Z. Tardieu (Evreux, France)
A comparative study of the safety, tolerability, pharmacodynamics (PD) and pharmacokinetics (PK) of salmeterol HFA and CFC MDI inhalers in healthy subjects R. D. Kempsford, M. L. Handel, R. Mehta, M. De Silva, P. T. Daley-Yates (Greenford, United Kingdom; Randwick, Australia; Raleigh-Durham, United States Of America)
Non-inferior efficacy of hydrofluoroalkane (HFA) salmeterol (SALM) metered dose inhaler (MDI) compared to salmeterol chlorofluorocarbon (CFC) in adolescent & adult patients with persistent asthma N. Chopra, M. Rimmer, M. Williams, M. Jenkins, on Behalf of Int Study Team SMO30006 (Greenford, United Kingdom)
Salmeterol metered dose inhaler (MDI) propelled by hydrofluoroalkane (HFA) is non-inferior to salmeterol chlorofluorocarbon (CFC) propelled MDI in paediatic patients with persistent asthma N. Chopra, M. Rimmer, M. Williams, M. Jenkins, on Behalf of Int Study Team SMO30007 (Greenford, United Kingdom)
High lung deposition of ^99mTc-labelled ciclesonide administered via HFA-MDI to asthma patients S. Newman, A. Salmon, R. Nave, A. Drollmann (Ruddington, United Kingdom; Konstanz, Germany)
Airway and systemic effects of hydrofluoroalkane formulations of high dose ciclesonide and fluticasone propionate in moderate persistent asthma D. K. C. Lee, B. J. Lipworth (Dundee, United Kingdom)
Equivalent pharmacokinetics of the active metabolite of ciclesonide when using the ciclesonide-MDI with and without a spacer R. Nave, E. Baumgärtner, T. D. Bethke, V. W. Steinijans, A. Drollmann (Konstanz, Freiburg, Germany)
High nonrespiratory fraction of drug delivered by diskus compared with turbuhaler correlates with elevated side-effects levels T. L. G. Andersson, R. Aalbers, L. Asking (Lund, Sweden; Groningen, The Netherlands)
Efficacy of homemade vs. commercial spacers in asthma treatment S. Kiliçli, C. Karlikaya (Bursa, Edirne, Turkey)
In-use performance of sofotec´s dry powder inhaler M. Wedel, B. Fyrnys (Frankfurt, Germany)
The comparison of dispersed compositions of drug aerosols generated from an aqueous suspension, aqueous and glycolic solutions T. N. Garkavaya, S. Y. Skachilova, M. A. Denisov, V. M. Pavlov, N. A. Trofimov (Staraya Kupavna, Vladimir, Russia)
The assesment of aerosol solution lung deposition in cystic fibrosis patients C. M. Coldham, T. Davies, S. Mulrennan, J. Seymour, G. Wright, A. Morice (Hull, United Kingdom)